Completed PHASE2 INTERVENTIONAL 2-arm NCT00303446

Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)

Phase II Clinical Trial to Examine the Efficacy and Safety of Dutasteride in Patients With Kennedy's Disease (Spinal and Bulbar Muscular Atrophy)

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Conditions Kennedy's Disease Spinal and Bulbar Muscular Atrophy

Interventions Dutasteride Placebo

Updated 5 times since 2017 Last updated: Jan 25, 2011 Started: Mar 31, 2006 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00303446, this PHASE2 trial focuses on Kennedy's Disease and Spinal and Bulbar Muscular Atrophy and remains completed. Sponsored by National Institute of Neurological Disorders and Stroke (NINDS), it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Neurological Disorders and Stroke (NINDS)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States